Vanda Pharmaceuticals (VNDA) Enterprise Value (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.32% |
| Dec 31, 2025 | 10.18% |
| Sep 30, 2025 | 9.77% |
| Jun 30, 2025 | 4.51% |
| Mar 31, 2025 | 9.00% |
| Dec 31, 2024 | 0.43% |
| Sep 30, 2024 | 2.94% |
| Jun 30, 2024 | 1.64% |
| Mar 31, 2024 | -1.51% |
| Dec 31, 2023 | 20.74% |
| Sep 30, 2023 | -0.10% |
| Jun 30, 2023 | 2.42% |
| Mar 31, 2023 | -7.42% |
| Dec 31, 2022 | -2.65% |
| Sep 30, 2022 | -3.16% |
| Jun 30, 2022 | -1.31% |
| Mar 31, 2022 | -0.55% |
| Dec 31, 2021 | -6.61% |
| Sep 30, 2021 | -2.39% |
| Jun 30, 2021 | -4.85% |
| Mar 31, 2021 | -2.83% |
| Dec 31, 2020 | -5.51% |
| Sep 30, 2020 | -2.56% |
| Jun 30, 2020 | -8.81% |
| Mar 31, 2020 | -0.06% |
| Dec 31, 2019 | -31.27% |
| Sep 30, 2019 | 15.13% |
| Jun 30, 2019 | -4.60% |
| Mar 31, 2019 | -4.07% |
| Dec 31, 2018 | -6.98% |
| Sep 30, 2018 | -4.05% |
| Jun 30, 2018 | 7.08% |
| Mar 31, 2018 | -73.51% |
| Dec 31, 2017 | -2.53% |
| Sep 30, 2017 | -2.02% |
| Jun 30, 2017 | 0.46% |
| Mar 31, 2017 | 31.75% |
| Dec 31, 2016 | -41.56% |
| Sep 30, 2016 | -4.85% |
| Jun 30, 2016 | 1.69% |
| Mar 31, 2016 | 3.39% |
| Dec 31, 2015 | 0.79% |
| Sep 30, 2015 | 1.58% |
| Jun 30, 2015 | -9.16% |
| Mar 31, 2015 | -3.47% |
| Dec 31, 2014 | -131.46% |
| Sep 30, 2014 | 11.79% |
| Jun 30, 2014 | 36.67% |
| Mar 31, 2014 | 22.98% |
| Dec 31, 2013 | 8.32% |
| Sep 30, 2013 | -37.19% |
| Jun 30, 2013 | 6.58% |
| Mar 31, 2013 | 7.87% |
| Dec 31, 2012 | 10.42% |
| Sep 30, 2012 | 7.12% |
| Jun 30, 2012 | 7.98% |
| Mar 31, 2012 | -5.62% |
| Dec 31, 2011 | 7.78% |
| Sep 30, 2011 | 14.31% |
| Jun 30, 2011 | -258.72% |
| Mar 31, 2011 | 73.48% |
| Dec 31, 2010 | -93.27% |
| Sep 30, 2010 | 29.65% |